-
1دورية أكاديمية
المؤلفون: Truman, I, Milligan, G, Modi, H, Murray, N, Adlard, NE
المصدر: In Value in Health December 2022 25(12) Supplement:S243-S244
-
2دورية أكاديمية
المؤلفون: Farhane, F, Bhan, V, Clift, F, Baharnoori, M, Thomas, K, Patel, BP, Blanchette, F, Adlard, NE, Vudumula, U, Gudala, K, Dutta, N, Grima, D, Mouallif, S
المصدر: In Value in Health December 2022 25(12) Supplement:S55-S56
-
3دورية أكاديمية
المؤلفون: Mouallif, S, Thomas, K, Adlard, NE, Cooney, P, Blanchette, F, Patel, BP, Baharnoori, M, Bhan, V, Clift, F, Grima, D
المصدر: In Value in Health January 2022 25(1) Supplement:S63-S63
-
4دورية أكاديمية
المؤلفون: Adlard, NE, Panpurina, A, Patel, VJ, Khurana, V, Medin, J, Kubara, A
المصدر: In Value in Health October 2018 21 Supplement 3:S351-S351
-
5دورية أكاديمية
المؤلفون: Adlard, NE, Panpurina, A, Patel, VJ, Khurana, V, Medin, J, Kubara, A
المصدر: In Value in Health October 2018 21 Supplement 3:S350-S351
-
6دورية أكاديمية
المؤلفون: Steeves, S, Beaver, S, Ashworth, L, Summers, J, Adlard, NE, Kroes, M
المصدر: In Value in Health October 2018 21 Supplement 3:S350-S350
-
7دورية أكاديمية
المؤلفون: Adlard, NE, Watson, J, Bottomley, CJ, Kroes, M
المصدر: In Value in Health October 2018 21 Supplement 3:S348-S348
-
8دورية أكاديمية
المؤلفون: Adlard, NE, Rendas-Baum, R., Bjorner, JB, Rychlec, K, Khurana, V, Medin, J
المصدر: In Value in Health October 2018 21 Supplement 3:S390-S390
-
9دورية أكاديمية
المؤلفون: Morgan, C, Adlard, NE, Carroll, SM
المصدر: In Value in Health 2010 13(7):A369-A369
-
10دورية أكاديمية
المؤلفون: Noon KM; a Costello Medical Consulting Ltd , London , UK., Montgomery SM; b Costello Medical Consulting Ltd , Cambridge , UK., Adlard NE; c Novartis Pharma AG , Basel , Switzerland., Kroes MA; d Novartis Pharmaceuticals UK Ltd , Surrey , UK.
المصدر: Journal of medical economics [J Med Econ] 2018 Oct; Vol. 21 (10), pp. 983-992. Date of Electronic Publication: 2018 Jul 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE
مواضيع طبية MeSH: Models, Economic*, Immunosuppressive Agents/*economics , Immunosuppressive Agents/*therapeutic use , Multiple Sclerosis, Relapsing-Remitting/*drug therapy , Technology Assessment, Biomedical/*methods, Adult ; Alemtuzumab/economics ; Alemtuzumab/therapeutic use ; Cost-Benefit Analysis ; Dimethyl Fumarate/economics ; Dimethyl Fumarate/therapeutic use ; Female ; Fingolimod Hydrochloride/economics ; Fingolimod Hydrochloride/therapeutic use ; Health Resources/economics ; Health Resources/statistics & numerical data ; Health Services/economics ; Health Services/statistics & numerical data ; Humans ; Male ; Markov Chains ; Natalizumab/economics ; Natalizumab/therapeutic use